Completed
Phase 3 Study of KHK7580
NCT02549404
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin Tokyo, Japan